Navigation Links
Cancer Genome Institute at Fox Chase among first to offer clinical blueprint of cancer genes

PHILADELPHIA (January 7, 2013)Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, is now offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes.

The new clinical test, known as CancerCode-45TM, evaluates an individual's tumor for genetic alterations in a select group of 45 genes and gives physicians the opportunity to look at the alterations and be even more precise when choosing a course of treatment. The test is being offered through the Cancer Genome Institute at Fox Chaseone of only a few centers in the nation to offer such pioneering technology in cancer molecular diagnostics.

"Gaining insight like this into the DNA of a specific tumor is the next step in transforming cancer care and prevailing over cancer," says Michael V. Seiden, MD, PhD, president and CEO of Fox Chase. "We are very excited to be offering this innovative test at our Center and look forward to the ways it will enhance the care we provide our patients."

Using leading-edge technology, physicians and scientists at Fox Chase are able to perform the CancerCode-45 test and analyze the genetic information in the DNA of a patient's tumor to find changes that are crucial to supporting their cancer. This genetic analysis will examine multiple alterations in 45 cancer-related genes and provide a report to the patient's treating physician.

Prior to the CancerCode-45 test being performed, patients will need to see a Fox Chase physician to provide information about their background, medical history, current medications, and ability to perform daily activities. In addition, the physician will need to take a blood sample and a sample of the tumor (which can come from a previous surgery or biopsy that the patient might have had). It takes about 20 working days to get each patient's test results.

"Not every patient will benefit from this test, but for some it could very well change their entire course of treatment and significantly prolong their life," says Jeff Boyd, PhD, executive director of the Cancer Genome Institute at Fox Chase. "At the very least, the results may help physicians decide how to treat their patients with advanced cancerwhether by suggesting they use a particular type of drug or not use a particular type of drug or by allowing them to take part in clinical trials of new medications guided by their tumor's genetic profile."


Contact: Diana Quattrone
Fox Chase Cancer Center

Related medicine news :

1. Ovarian cancer stem cell study puts targeted therapies within reach
2. How prostate cancer therapies compare by cost and effectiveness
3. Mayo Clinic researchers find new molecule to target in pancreatic cancer treatment
4. Scientists discover how deadly skin cancer spreads into other parts of the body
5. Some Complain of Shorter Penis After Prostate Cancer Treatment: Study
6. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
7. Author of the Uplifting Cancer Survival Guide, The C Card and Me, Opens Online Shop with Inspiring Gifts for Cancer Patients, Survivors and Caregivers
8. Some men voice complaints of shortened penis following prostate cancer treatment
9. Common data determinants of recurrent cancer are broken, mislead researchers
10. PET/CT shows clear advantages over conventional staging for breast cancer patients
11. PRMA Pink Ladies Gaining Members Across the Country Through Monthly Live Internet Meetings, Offering Support and Inspiration to Breast Cancer Survivors
Post Your Comments:
(Date:10/13/2015)... ... ... "My friend's son suffers from eczema, and he had a horrible habit ... Platteville, Colo. "I came up with this kit as a way to prevent children ... child from rubbing or scratching his or her face. This protects sensitive skin from ...
(Date:10/13/2015)... ... , ... ProText Kinetic Panel is a typography creation tool made for use ... energetic text animations in any layout without the use of keyframes. Using ProText Kinetic ... stylize the text. With intuitive on-screen controls, users can re-position and scale the text. ...
(Date:10/13/2015)... ... October 13, 2015 , ... Relay (, ... application, announced today a significant contract that will provide its award-winning private messaging ... build on the growing success of its Relay program, IBX Wire™, which now ...
(Date:10/13/2015)... ... October 13, 2015 , ... Leading ... Singal's newly launched "Publish Academy" training course . Singal's new program, in ... enrollment today, and marketers around the Internet are weighing in with reviews. , ...
(Date:10/13/2015)... ... October 13, 2015 , ... T-System ... with more than 59,000 emergency department visits per year, today announced the successful ... to help improve clinical, operational and financial outcomes. , In less ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... 2015  Kay Elledge, M.D., an established South ... of Obstetrics and Gynecology (FACOG) for the past ... Genuine Self Medical Laser Center where she provides ... of Breast Cancer Awareness Month , the ... MonaLisa Touch treatments initiated in the month ...
(Date:10/13/2015)... 13, 2015  Human Longevity, Inc. (HLI), the genomics-based, ... announced today the launch of the company,s first Health ... the potential to transform healthcare. The inaugural Health Nucleus ... , at HLI,s headquarters facility. More Health Nucleus facilities ... and International cities. --> ...
(Date:10/13/2015)... SAN DIEGO , Oct. 13, 2015 /PRNewswire/ ... bioelectronics for use in research and diagnostics, announces ... of $1.6 million led by Serra Ventures. ... Nanomed,s mission is providing low-cost, easy-to-use monitoring and ... personal health decisions. The funding round will enable ...
Breaking Medicine Technology: